These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 23409080)

  • 21. Targeting the IL-4/IL-13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs.
    Natoli A; Lüpertz R; Merz C; Müller WW; Köhler R; Krammer PH; Li-Weber M
    Int J Cancer; 2013 Oct; 133(8):1945-54. PubMed ID: 23553437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas.
    Nettersheim D; Arndt I; Sharma R; Riesenberg S; Jostes S; Schneider S; Hölzel M; Kristiansen G; Schorle H
    Br J Cancer; 2016 Aug; 115(4):454-64. PubMed ID: 27441500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoic acid 4-hydroxylase-mediated catabolism of all-trans retinoic acid and the cell proliferation in head and neck squamous cell carcinoma.
    Kim SY; Yoo SJ; Kwon HJ; Kim SH; Byun Y; Lee KS
    Metabolism; 2002 Apr; 51(4):477-81. PubMed ID: 11912557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased PRAME-specific CTL killing of acute myeloid leukemia cells by either a novel histone deacetylase inhibitor chidamide alone or combined treatment with decitabine.
    Yao Y; Zhou J; Wang L; Gao X; Ning Q; Jiang M; Wang J; Wang L; Yu L
    PLoS One; 2013; 8(8):e70522. PubMed ID: 23940586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NF-kappaB-independent down-regulation of XIAP by bortezomib sensitizes HL B cells against cytotoxic drugs.
    Kashkar H; Deggerich A; Seeger JM; Yazdanpanah B; Wiegmann K; Haubert D; Pongratz C; Krönke M
    Blood; 2007 May; 109(9):3982-8. PubMed ID: 17185461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Preferentially Expressed Antigen of Melanoma as a Potential Tumor Suppressor in Lung Adenocarcinoma.
    Huang Q; Li L; Lin Z; Xu W; Han S; Zhao C; Li L; Cao W; Yang X; Wei H; Xiao J
    Med Sci Monit; 2016 May; 22():1837-42. PubMed ID: 27241212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRABP-II methylation: a critical determinant of retinoic acid resistance of medulloblastoma cells.
    Fu YS; Wang Q; Ma JX; Yang XH; Wu ML; Zhang KL; Kong QY; Chen XY; Sun Y; Chen NN; Shu XH; Li H; Liu J
    Mol Oncol; 2012 Feb; 6(1):48-61. PubMed ID: 22153617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of PRAME enhances adriamycin-induced apoptosis in chronic myeloid leukemia cells.
    Yan H; Zhao RM; Wang ZJ; Zhao FR; Wang SL
    Eur Rev Med Pharmacol Sci; 2015 Dec; 19(24):4827-34. PubMed ID: 26744874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PRAME promotes epithelial-to-mesenchymal transition in triple negative breast cancer.
    Al-Khadairi G; Naik A; Thomas R; Al-Sulaiti B; Rizly S; Decock J
    J Transl Med; 2019 Jan; 17(1):9. PubMed ID: 30602372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
    Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
    JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-associated antigen preferentially expressed antigen of melanoma (PRAME) induces caspase-independent cell death in vitro and reduces tumorigenicity in vivo.
    Tajeddine N; Gala JL; Louis M; Van Schoor M; Tombal B; Gailly P
    Cancer Res; 2005 Aug; 65(16):7348-55. PubMed ID: 16103086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of the mouse X-linked Prame gene causes germ cell reduction in spermatogenesis.
    Lu C; Yang M; Rossi RM; Wang A; Feitosa WB; Diaz FJ; Liu WS
    Mol Reprod Dev; 2020 Jun; 87(6):666-679. PubMed ID: 32017313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative monitoring of the PRAME gene for the detection of minimal residual disease in leukaemia.
    Matsushita M; Ikeda H; Kizaki M; Okamoto S; Ogasawara M; Ikeda Y; Kawakami Y
    Br J Haematol; 2001 Mar; 112(4):916-26. PubMed ID: 11298586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.
    Atanackovic D; Luetkens T; Kloth B; Fuchs G; Cao Y; Hildebrandt Y; Meyer S; Bartels K; Reinhard H; Lajmi N; Hegewisch-Becker S; Schilling G; Platzbecker U; Kobbe G; Schroeder T; Bokemeyer C; Kröger N
    Am J Hematol; 2011 Nov; 86(11):918-22. PubMed ID: 21898529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity.
    Quere R; Baudet A; Cassinat B; Bertrand G; Marti J; Manchon L; Piquemal D; Chomienne C; Commes T
    Blood; 2007 May; 109(10):4450-60. PubMed ID: 17218384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melittin Increases Cisplatin Sensitivity and Kills KM-H2 and L-428 Hodgkin Lymphoma Cells.
    Kreinest T; Volkmer I; Staege MS
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human bone marrow niche chemoprotection mediated by cytochrome P450 enzymes.
    Alonso S; Su M; Jones JW; Ganguly S; Kane MA; Jones RJ; Ghiaur G
    Oncotarget; 2015 Jun; 6(17):14905-12. PubMed ID: 25915157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic regulation of PRAME in acute myeloid leukemia is different compared to CD34+ cells from healthy donors: effect of 5-AZA treatment.
    Gutierrez-Cosío S; de la Rica L; Ballestar E; Santamaría C; Sánchez-Abarca LI; Caballero-Velazquez T; Blanco B; Calderón C; Herrero-Sánchez C; Carrancio S; Ciudad L; Cañizo C; San Miguel JF; Pérez-Simón JA
    Leuk Res; 2012 Jul; 36(7):895-9. PubMed ID: 22503131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of
    Lucci V; De Marino E; Tagliaferri D; Amente S; Pollice A; Calabrò V; Vivo M; Falco G; Angrisano T
    Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of nucleophosmin by RNA interference reverses multidrug resistance in resistant leukemic HL-60 cells.
    Lin M; Hu J; Liu T; Li J; Chen B; Chen X
    Immunobiology; 2013 Sep; 218(9):1147-54. PubMed ID: 23669237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.